HERNANDEZ JOSEPH (Chief Executive Officer) received a stock award from CLARUS THERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/14/2021ACC: 0000899243-21-048205
DirectorOfficer10% Owner· Chief Executive Officer
Since Dec 2020
+13.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
13.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.84K
Price / share
—
Trade value
—
% of position
New position
12/12/2021
0.00→3.84K
Total
Net shares
+3.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2021 | A · Award | +3.84K | — | — | New position | 0.00 | 3.84K |
| Total | +3.84K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.61K shares
Shares
+9.61K
Strike price
4.78
Held after
9.61K
Exercisable
—
12/12/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock9.61K shares | 12/12/2021 | A · Award | +9.61K | 4.78 | — | 9.61K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.30M
Total
1.30M indirect1.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Indirect |
| Total | 1.30M | 1.30M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported